FDA Approved: LEXISCAN — Original Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved LEXISCAN (regadenoson) under its original NDA from Astellas for pharmacologic stress imaging to evaluate suspected coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Lexiscan (regadenoson)

Snippet

ORIG AP for LEXISCAN (REGADENOSON)